Residual pain and ultrasound activity in patients with Rheumatoid Arthritis in clinical remission or low disease activity treated with JAK inhibitors: a multicenter cross-sectional study aimed at identifying difficult-to-treat patients

tofacitinib - Generic mfg.

Jyseleca (filgotinib) - Gilead

Rinvoq (upadacitinib) - AbbVie

Olumiant (baricitinib) - Eli Lilly

https://distribution-congress.eular.org/from.storage?image=15rRXWmdOAJ77zPlkD-rQqe0I0O_lEHMr8E4o7QBssfzhCb0oIJl5fYuTkKtPiqz0

Nikita Pecani1; Riccardo Terribili2; Cristiano Barbetta1; Maurizio Benucci3; Simona Buonanno2; Anna Capogna2; Caterina Baldi2; Stefano Gentileschi2; Luigi De Marco4; Arianna D'Antonio4; Ettore Silvagni5; Maria Sole Chimenti4; Serena Guiducci1

May 23, 2026